Nigeria is one of the world’s leading origins for dried roselle (Hibiscus sabdariffa), yet almost all of its supply is informal, uncertified and untraceable, precisely the gap that caused it to lose its single largest export market. Premium Hibiscus is designed to convert that structural weakness into a durable competitive position.

The opportunity

Global demand for hibiscus calyces, used in herbal teas, the Mexican beverage agua de jamaica, nutraceuticals, natural food colour and, domestically, the Nigerian drink zobo, is large, growing and increasingly quality-sensitive. Nigeria is a top-tier producer, but its trade is fragmented across informal traders with weak phytosanitary control. A 2016–17 khapra-beetle infestation cost Nigeria access to Mexico, its largest market; despite a 2023 bilateral work plan, that access remains constrained in practice. Buyers in the EU, US and Asia increasingly demand certified, traceable, food-safe supply that the incumbent trade cannot reliably provide.

Premium Hibiscus addresses this by building an integrated origin platform: a company-operated nucleus estate for quality and traceability, a structured outgrower network of thousands of smallholders for scale, and a central processing and export hub with in-house cleaning, grading, laboratory quality control and dedicated fumigation, directly remediating the exact failure that closed the Mexican market.

Why the economics work

The venture captures the farmgate-to-FOB value spread, upgrades product mix toward certified and value-added grades, and benefits from a natural currency position: revenue is earned in USD while the cost base is largely in naira. Revenue scales from USD 1.6m to USD 18.2m over five years; the gross margin widens from ~15% to ~33% as scale lowers unit processing cost and the mix improves; and the business crosses into positive EBITDA in Year 3, reaching a ~20% EBITDA margin by Year 5.

The ask and the returns

The Company seeks a blended package of USD 6.0m equity in three milestone-linked tranches, a USD 3.0m DFI-blended term loan (7-year, 3-year principal moratorium) for capital expenditure, and a USD 4.5m trade-finance revolver for the seasonal working-capital swing. On a 5.5x Year-5 EBITDA exit, the base case returns approximately 3.09x MOIC and a ~29% equity IRR. These are attractive, growth-stage returns, but they are earned across a genuine J-curve with two years of negative earnings, and they are sensitive to price, the exit multiple and execution discipline on working capital.

Snapshot of the five-year plan

Table 1. Base-case financial summary. Figures reconcile to the integrated model in Section 18.